Free Trial
OTCMKTS:CYAN

Cyanotech Q2 2027 Earnings Results & Report

Cyanotech logo
$0.59 -0.02 (-3.28%)
As of 11/13/2026 03:17 PM Eastern

Cyanotech reported Q2 2027 earnings on November 10, 2026. The company reported EPS of $0.12, while revenue was $7.96 million.

Earnings Announcement Details

Quarter
Q2 2027
Time
Before Market Opens

Cyanotech EPS Results

Actual EPS
$0.12
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Cyanotech Revenue Results

Actual Revenue
$7.96 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Cyanotech Q2 2027 Earnings FAQ

Cyanotech (OTCMKTS:CYAN) reported earnings of $0.12 per share for Q2 2027. The report was announced on Tuesday, November 10, 2026.

Cyanotech reported revenue of $7.96 million for Q2 2027.

Cyanotech Earnings Headlines

The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
Cyanotech Corp.
See More Cyanotech Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cyanotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cyanotech and other key companies, straight to your email.

About Cyanotech

Cyanotech (OTCMKTS:CYAN) is a Hawaii-based producer of specialty health and nutrition products derived from microalgae. The company cultivates microalgae in open ponds at its facility on the Kona coast of Hawaii and processes the biomass into nutritional supplements and ingredient products.

Its primary products include Hawaiian Spirulina Pacifica, a spirulina-based nutritional supplement, and BioAstin Hawaiian Astaxanthin, a natural antioxidant derived from the microalga Haematococcus pluvialis. Cyanotech has marketed these products for use in dietary supplements, functional foods and other health-related applications.

Founded in 1983, Cyanotech has served consumer and commercial customers through its own product brands, distributors and ingredient sales channels. Its products have been marketed in the United States and internationally, although the availability of specific products and distribution arrangements may vary by geography.

View Cyanotech Profile